VCP regulates early tau seed amplification via specific cofactors.

Autor:	Batra S; UT Southwestern: The University of Texas Southwestern Medical Center., Vaquer-Alicea JI; UT Southwestern: The University of Texas Southwestern Medical Center., Valdez C; UT Southwestern: The University of Texas Southwestern Medical Center., Taylor SP; UT Southwestern: The University of Texas Southwestern Medical Center., Manon VA; UT Southwestern: The University of Texas Southwestern Medical Center., Vega AR; UT Southwestern: The University of Texas Southwestern Medical Center., Kashmer OM; UT Southwestern: The University of Texas Southwestern Medical Center., Kolay S; UT Southwestern: The University of Texas Southwestern Medical Center., Lemoff A; UT Southwestern: The University of Texas Southwestern Medical Center., Cairns NJ; University of Exeter Faculty of Health and Life Sciences., White CL; UT Southwestern: The University of Texas Southwestern Medical Center., Diamond MI; UT Southwestern: The University of Texas Southwestern Medical Center.
Jazyk:	angličtina
Zdroj:	Research square [Res Sq] 2024 May 22. Date of Electronic Publication: 2024 May 22.
DOI:	10.21203/rs.3.rs-4307848/v1
Abstrakt:	Background: Neurodegenerative tauopathies may progress based on seeding by pathological tau assemblies, whereby an aggregate is released from one cell, gains entry to an adjacent or connected cell, and serves as a specific template for its own replication in the cytoplasm. In vitro seeding reactions typically take days, yet seeding into the complex cytoplasmic milieu happens within hours, implicating a machinery with unknown players that controls this process in the acute phase. Methods: We used proximity labeling to identify factors that control seed amplification within 5h of seed exposure. We fused split-APEX2 to the C-terminus of tau repeat domain (RD) to reconstitute peroxidase activity 5h after seeded intracellular tau aggregation. Valosin containing protein (VCP/p97) was the top hit. VCP harbors dominant mutations that underlie two neurodegenerative diseases, multisystem proteinopathy and vacuolar tauopathy, but its mechanistic role is unclear. We used immortalized cells and human neurons to study the effects of VCP on tau seeding. We exposed cells to fibrils or brain homogenates in cell culture media and measured effects on uptake and induction of intracellular tau aggregation following various genetic and chemical manipulations of VCP. Results: VCP knockdown reduced tau seeding. Chemical inhibitors had opposing effects on aggregation in HEK293T tau biosensor cells and human neurons alike: ML-240 increased seeding efficiency, whereas NMS-873 decreased it. The inhibitors were effective only when administered within 8h of seed exposure, indicating a role for VCP early in seed processing. We screened 30 VCP co-factors in HEK293T biosensor cells by genetic knockout or knockdown. Reduction of ATXN3, NSFL1C, UBE4B, NGLY1, and OTUB1 decreased tau seeding, as did NPLOC4, which also uniquely increased soluble tau levels. By contrast, reduction of FAF2 increased tau seeding. Conclusions: Divergent effects on tau seeding of chemical inhibitors and cofactor reduction indicate that VCP regulates this process. This is consistent with a dedicated cytoplasmic processing complex based on VCP that directs seeds acutely towards degradation vs. amplification. Competing Interests: Competing interests The authors declare no competing interests.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu